Karlsen T H, Boberg K M, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie B A
Medical Department, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway.
Genes Immun. 2007 Apr;8(3):275-8. doi: 10.1038/sj.gene.6364377. Epub 2007 Feb 15.
Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have inflammatory bowel disease (IBD), the majority ulcerative colitis (UC). An inherent problem in interpreting positive findings in genetic association studies of PSC is thus to distinguish between factors associated with hepatobiliary versus intestinal pathology. We aimed to clarify to what extent human leukocyte antigen (HLA) class II associations in UC patients with and without PSC differ. High-resolution DRB1 and DQB1 typing was performed in 365 Scandinavian PSC patients, an independent cohort of 330 Norwegian UC patients and 368 healthy controls. HLA associations found in PSC were mostly distinct from those seen in UC, and no significant differences were noted between PSC patients with concurrent UC and PSC patients without IBD. This suggests different HLA associated genetic susceptibility to PSC and UC, and supports notions that UC in PSC may represent a distinct UC phenotype.
北欧原发性硬化性胆管炎(PSC)患者中约80%患有炎症性肠病(IBD),其中大多数为溃疡性结肠炎(UC)。因此,在PSC的基因关联研究中解释阳性结果时,一个内在问题是区分与肝胆病理和肠道病理相关的因素。我们旨在阐明伴或不伴PSC的UC患者中人类白细胞抗原(HLA)II类关联的差异程度。对365例斯堪的纳维亚PSC患者、330例挪威UC患者的独立队列以及368例健康对照进行了高分辨率DRB1和DQB1分型。PSC中发现的HLA关联大多与UC中所见不同,并发UC的PSC患者与无IBD的PSC患者之间未发现显著差异。这表明PSC和UC存在不同的HLA相关遗传易感性,并支持PSC中的UC可能代表一种独特的UC表型的观点。